蛋白质体学市场规模、份额及成长分析（按仪器技术、试剂、服务、软体、应用、最终用户和地区）－2025-2032 年产业预测

2023 年蛋白质体学市场规模价值 318 亿美元，预计将从 2024 年的 361.6 亿美元成长到 2032 年的 1,009.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 13.7%。

慢性病的盛行率不断上升，预计到 2022 年将有 2,000 万例新发癌症病例，这是蛋白质体学市场成长的主要驱动力。对高效诊断方法日益增长的需求，推动蛋白质体学在药物开发和研发领域应用的扩展，进一步扩大了市场。蛋白质体学是一门研究生物系统中蛋白质的复杂作用和关係的领域，在识别疾病和发现新的治疗方法发挥关键作用。透过细緻分析蛋白质的结构、功能以及与 RNA 和 DNA 等其他分子的相互作用，蛋白质体学有助于我们理解复杂的生物过程并推动医疗保健解决方案的发展。因此，蛋白质体学市场在应对紧迫的医疗挑战的过程中正在经历强劲成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 专利分析
• 监管分析
• 案例研究
• 客户和购买标准分析
• 贸易分析

蛋白质体学市场规模（依仪器技术及复合年增长率） (2025-2032)

• 市场概览
• 光谱学
  • 质谱法
  • 核磁共振波谱
  • 圆二色谱
• 层析法
  • 高效液相层析
  • 离子层析法
  • 亲和层析法
  • 超临界流体层析
• 电泳
  • 凝胶电泳
  • 毛细管电泳
• 蛋白质微阵列
  • 生物晶片
  • 实验室晶片
  • 蛋白质晶片
  • 微阵列仪器
  • 整合系统
  • 微阵列扫描仪
  • 阿莱耶尔
• X射线结晶
• 表面等离子体共振
• 蛋白质分馏
• 其他测量技术

蛋白质体学市场规模（按试剂和复合年增长率） (2025-2032)

• 市场概览
• 免疫检测
• 光谱试剂
• 层析法试剂
• 蛋白质微阵列试剂
• X射线结晶试剂
• 电泳试剂
• 蛋白质分离试剂
• 其他试剂

蛋白质体学市场规模（依服务及复合年增长率） (2025-2032)

• 市场概览
• 核心蛋白质体学服务
  • 蛋白质鑑定服务
  • 定量蛋白质体学服务
  • 蛋白质表征服务
  • 蛋白质精製服务
  • 蛋白质分离服务
  • 蛋白质序列分析服务
  • 自订检测服务
• 生物资讯服务

蛋白质体学市场规模（依软体划分）及复合年增长率（2025-2032）

• 市场概览
• 生物资讯学工具
• 生物资讯资料库

蛋白质体学市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概览
• 临床诊断
  • 癌症
  • 感染疾病
  • 糖尿病
  • 神经系统疾病
  • 自体免疫疾病
  • 心血管疾病
  • 其他临床诊断应用
• 药物研发
  • 目标发现
  • 线索识别
  • 先导药物最适化
  • 临床前研究
• 其他用途

蛋白质体学市场规模（依最终用户划分）及复合年增长率（2025-2032）

• 市场概览
• 生物製药公司
• 学术研究所
• 医院
• 临床实验室
• 其他最终用户

蛋白质体学市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific（USA）
• Agilent Technologies（USA）
• Waters Corporation（USA）
• Bruker Corporation（Germany）
• Danaher Corporation（USA）
• GE Healthcare Life Sciences（UK）
• Bio-Rad Laboratories（USA）
• Shinwa Chemical Industries（Japan）
• Nexelis（Canada）
• Proteome Sciences（UK）
• Kyowa Kirin（Japan）

结论和建议

Proteomics Market size was valued at USD 31.8 billion in 2023 and is poised to grow from USD 36.16 billion in 2024 to USD 100.99 billion by 2032, growing at a CAGR of 13.7% during the forecast period (2025-2032).

The rising incidence of chronic illnesses, including an estimated 20 million new cancer cases in 2022, is significantly propelling the growth of the proteomics market. As the demand for efficient diagnostic methods escalates, the expanding applications of proteomics in drug development and research further enhance this market. Proteomics-a field study focusing on the intricate roles and relationships of proteins within biological systems-plays a crucial role in disease identification and the exploration of novel treatment options. By meticulously analyzing protein structures, functions, and interactions with other molecules such as RNA and DNA, proteomics contributes to understanding complex biological processes and fosters advancements in healthcare solutions. As such, the proteomics market is experiencing robust expansion as it addresses urgent medical challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Proteomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Proteomics Market Segments Analysis

Global Proteomics Market is segmented by Instrumentation Technology, Reagent, Service, Software, Application, End User and region. Based on Instrumentation Technology, the market is segmented into Spectroscopy,Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation and Other Instrumentation Technologies. Based on Reagent, the market is segmented into Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents and Other Reagents. Based on Service, the market is segmented into Core Proteomics Services and Bioinformatics Services. Based on Software, the market is segmented into Bioinformatics Tools and Bioinformatics Databases. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Other Applications. Based on End User, the market is segmented into Biopharmaceutical Companies, Academic And Research Institutes, Hospitals, Clinical Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Proteomics Market

The proteomics market is primarily driven by significant advancements in technology that have dramatically enhanced sensitivity and resolution. These innovations have not only allowed for high-throughput and multiplexed analyses but also improved data integration and sample preparation methods. Such developments have transformed the understanding of the proteome, leading to a more comprehensive exploration of proteins and their functions. As a result, these breakthroughs have played a pivotal role in stimulating the growth of the proteomics market, paving the way for new applications and research opportunities that capitalize on advanced analytical capabilities.

Restraints in the Proteomics Market

One significant restraint in the proteomics market is the challenge of navigating disparate regulatory frameworks across different countries. The lack of universally accepted standards can complicate the adoption of proteomic technologies, as varying regulations may restrict their implementation. This inconsistency can hinder international collaborations and partnerships, ultimately resulting in prolonged product approval processes. Consequently, the absence of a cohesive regulatory environment creates barriers to market growth, as companies may face delays in launching their innovations and may struggle to meet differing compliance requirements across regions, thus stifling the overall potential of the proteomics industry.

Market Trends of the Proteomics Market

The global proteomics market is experiencing significant growth driven by rapid technological advancements in mass spectrometry and next-generation sequencing. These innovations enhance the sensitivity and accuracy of protein analysis, rendering complex biological processes more comprehensible to researchers. As a result, proteomics has become integral to biomarker discovery, facilitating the identification of specific proteins associated with various diseases. This trend reflects a broader demand for precision medicine, where tailored treatments can be developed based on detailed protein profiles. Consequently, the proteomics market is poised for sustained expansion, appealing to pharmaceutical and diagnostic sectors seeking innovative solutions in disease management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Case Studies
• Customer And Buying Criteria Analysis
• Trade Analysis

Global Proteomics Market Size by Instrumentation Technology & CAGR (2025-2032)

• Market Overview
• Spectroscopy
  • Mass Spectrometry
  • NMR Spectroscopy
  • CD Spectroscopy
• Chromatography
  • High-Performance Liquid Chromatography
  • Ion Chromatography
  • Affinity Chromatography
  • Supercritical Fluid Chromatography
• Electrophoresis
  • Gel Electrophoresis
  • Capillary Electrophoresis
• Protein Microarrays
  • Biochips
  • Lab-On-Chips
  • Protein Chips
  • Microarray Instruments
  • Integrated Systems
  • Microarray Scanners
  • Arrayers
• X-Ray Crystallography
• Surface Plasmon Resonance
• Protein Fractionation
• Other Instrumentation Technologies

Global Proteomics Market Size by Reagent & CAGR (2025-2032)

• Market Overview
• Immunoassay Reagents
• Spectroscopy Reagents
• Chromatography Reagents
• Protein Microarray Reagents
• X-Ray Crystallography Reagents
• Electrophoresis Reagents
• Protein Fractionation Reagents
• Other Reagents

Global Proteomics Market Size by Service & CAGR (2025-2032)

• Market Overview
• Core Proteomics Services
  • Protein Identification Services
  • Quantitative Proteomics Services
  • Protein Characterization Services
  • Protein Purification Services
  • Protein Separation Services
  • Protein Sequencing Services
  • Custom Assay Services
• Bioinformatics Services

Global Proteomics Market Size by Software & CAGR (2025-2032)

• Market Overview
• Bioinformatics Tools
• Bioinformatics Databases

Global Proteomics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Diagnostics
  • Cancer
  • Infectious Diseases
  • Diabetes
  • Neurological Disorders
  • Autoimmune Diseases
  • Cardiovascular Diseases
  • Other Clinical Diagnostic Applications
• Drug Discovery & Development
  • Target Discovery
  • Lead Identification
  • Lead Optimization
  • Preclinical Studies
• Other Applications

Global Proteomics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Biopharmaceutical Companies
• Academic And Research Institutes
• Hospitals
• Clinical Laboratories
• Other End Users

Global Proteomics Market Size & CAGR (2025-2032)

• North America (Instrumentation Technology, Reagent, Service, Software, Application, End User)
  • US
  • Canada
• Europe (Instrumentation Technology, Reagent, Service, Software, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Instrumentation Technology, Reagent, Service, Software, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Instrumentation Technology, Reagent, Service, Software, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Instrumentation Technology, Reagent, Service, Software, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare Life Sciences (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shinwa Chemical Industries (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexelis (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteome Sciences (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyowa Kirin (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations